• Home

  • Partners

  • Work Packages

  • News and Events

  • Intranet

  • Contact Us

  • Glossary

  • More

    SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools

    Achievements

    Navigation

    • Objectives

    • Achievements

    • Newsletter

    • Funding Partners

    • Participants

    • Publications

    • Contact

    Eye on it:

     

    SUMMIT delivers and reports back on its achievements

     

     

     

     

     

     

     

    SUMMIT is in its 6th and final year and most of the goals we set out to accomplish have by now been reached, creating a wealth of data and results on markers for Diabetes complications.

     

    Follow the links below for more detail on our major achievements.

     

    Summary of major achievements for SUMMIT, year 5

     

    Summary of major achievements for SUMMIT, year 4

     

    Summary of major achievements for SUMMIT, year 3

     

     

    © 2014 by IMI-SUMMIT. All rights reserved.

    Website design: Klodiana Jani

    MISSION

    T​o DISCOVER, DEVELOP and QUALIFY potential MARKERS that empower:

    ​

    • the identification of patients at high risk of diabetes complications

    • the monitoring of the complications' progression and patients‘ response to therapy 

    ​

    To use the discovered markers as SURROGATE ENDPOINTS in clinical trials.

    

    Thereby, SHORTEN the long lasting CLINICAL TRIALS to bring about EARLIER availability of NEW THERAPY to diabetic patients.

    Related Sites